Telehealth Transformation: Innovating Mental Health Care
Life Sciences Snapshot – Q1 2025
A Quarterly Report on Financing Trends
11 minute read | February.19.2025
After two years of declines, life sciences venture investment ended 2024 on a strong note. This edition highlights Q4 2024 investment trends and features a roundtable on telehealth transformation and innovation in mental healthcare.
Key findings include:
- Deal activity dipped from $8.6B in Q3 to $6.4B in Q4 but retained earlier gains.
- Valuations surged, with pre-seed/seed medians up 50% YoY and late-stage VC up 34.7%.
- Check sizes grew, especially in biotech AI and weight-loss drugs.
- Exits rose 62.4% YoY in value, though deal count fell, as IPOs made a comeback.
